Invention Grant
US09266853B2 Orally available viridiofungin derivative possessing anti-HCV activity
有权
具有抗HCV活性的口服有效的维生素E衍生物
- Patent Title: Orally available viridiofungin derivative possessing anti-HCV activity
- Patent Title (中): 具有抗HCV活性的口服有效的维生素E衍生物
-
Application No.: US14421577Application Date: 2013-08-16
-
Publication No.: US09266853B2Publication Date: 2016-02-23
- Inventor: Yasunori Kohchi , Kimitaka Nakama , Susumu Komiyama , Fumio Watanabe
- Applicant: Chugai Seiyaku Kabushiki Kaisha
- Applicant Address: JP Tokyo
- Assignee: Chugai Seiyaku Kabushiki Kaisha
- Current Assignee: Chugai Seiyaku Kabushiki Kaisha
- Current Assignee Address: JP Tokyo
- Agency: Foley & Larder LLP
- Priority: JP2012-181225 20120817
- International Application: PCT/JP2013/072034 WO 20130816
- International Announcement: WO2014/027696 WO 20140220
- Main IPC: C07D293/00
- IPC: C07D293/00 ; C07D317/00 ; C07D317/36 ; C07D293/06 ; C07D317/34 ; C07D317/40 ; C07C235/28 ; A61K31/192 ; A61K31/357 ; C07C235/74
Abstract:
An object of the present invention is to provide a compound that is useful as an orally available anti-HCV agent. The present invention relates to a compound represented by formula (1) or a pharmaceutically acceptable salt thereof. This compound has an anti-HCV activity and is useful as a medicine.
Public/Granted literature
- US20150210666A1 ORALLY AVAILABLE VIRIDIOFUNGIN DERIVATIVE POSSESSING ANTI-HCV ACTIVITY Public/Granted day:2015-07-30
Information query
